IT
Our Device
Our Med-Tech device – BMPOD – was created to address one of the most widespread and underestimated healthcare challenges: Musculoskeletal Disorders (MSDs) of postural origin.
A concrete solution, simple to use yet technologically advanced, designed to increase diagnostic precision, improve therapeutic interventions, and validate results scientifically.
Global Intellectual Property
Our innovation is protected by a granted European patent and ongoing international WIPO-PCT protection in:
Europe, USA, Brazil, Canada, China, Japan, Australia, Turkey, and South Korea.
Increases the company's asset value.
Guarantees market exclusivity.
Provides access to tax benefits such as the Patent Box.
Partnerships & Collaborations
Over the years, we have built a solid network of institutional and technical partners who form the backbone of our development:
Link University
Athlete testing, marketing strategies.
Studio Torta SpA
Legal consultancy and IP protection.
Quantum Leap Srl
Legal consultancy and IP protection.
Università di Tor Vergata
Clinical tests and technical validation.
Expert Lab Srl
Feasibility study.
Broken Bones Studio
Communication design, web design, corporate identity.
What Sets Us Apart
Market Gap
HMP is a first mover in a segment not yet covered, with great potential in healthcare, sports, and rehabilitation.
Validated Technology
Functional prototype, completed tests, solid IP valuation.
AI + Precision Medicine
Reliable measurements, personalized strategies, replicable data.
Concrete Support
Concrete Support agli operatori sanitari. Strumenti semplici da usare ma clinicamente avanzati.
Scientific Validation
Every component of our system is designed to provide measurable and replicable results.
Versatility
Our technology can be extended to multiple sectors: sports, rehabilitation, and diagnostics.
High Potential Return
Thanks to the strength of our IP, active collaborations, and strategic positioning, the opportunity for profit and exit is concrete and structured.
In summary: Why invest now?
We are on the threshold of the production phase. We have everything needed: patent, technology, expertise, and alliances.
Capital is now required to scale. The next investor will be an active part of a project destined to change how postural and musculoskeletal disorders are addressed.
“Together we can change the way the world takes care of its body.”